Archive
Proactive news headlines: Synairgen, Touchstone Exploration, Shanta Gold, ReNeuron …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Synairgen PLC
LON:SNG
Synairgen PLC is a UK-based respiratory company focused on drug discovery and the development of SNG001 (inhaled interferon beta) as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs for severe viral lung infections.
149 stories · page 4 of 8
Synairgen rockets as trial results could signal "major breakthrough" in treatment of severely ill COVID-19 patients
People who received SNG001, an inhaled formulation of interferon beta, had a 79% lower risk of developing the severe disease compared to those given the placebo, the data revealed
Synairgen says coronavirus (COVID-19) trial to be expanded nationally
Sufferers will receive the inhaled medication in their homes rather than at hospital
Synairgen completes hospital recruitment for coronavirus trial
Synairgen said a successful outcome for the trial would provide valuable information for the continued development of SNG001, an inhaled formulation of interferon-beta-1a, or coronavirus patients
Synairgen gets green light for home study of coronavirus inhaled drug; top line data expected in July
The idea is to treat sufferers earlier in the illness – within three days of developing symptoms
Synairgen surges as it extends SNG001 study to coronavirus patients in home environment
The aim of the extension is to dose patients with the treatment earlier in the infection cycle before severe lower respiratory tract symptoms develop
Archive
Small cap movers: AIM-listed companies raise £500mln in less than a month to cope with coronavirus crisis
A look back at some of the more interesting stories from London's junior market this week
Synairgen jumps as SNG001 trial on coronavirus patients labelled as an Urgent Public Health study
The company revealed on March 31 that the first patient was dosed in the double-blind, placebo-controlled trial at the University Hospital Southampton NHS Foundation Trust.
Synairgen starts dosing patients in coronavirus trials
"We are delighted to get this trial underway with the dosing of the first patient," said Richard Marsden, the chief executive officer of Synairgen
Synairgen raises £14mln in placing to fund coronavirus trial
The funding took place via firm and conditional placings carried out on Wednesday through a bookbuild by broker finnCap
Why the coronavirus crisis might not be as bad as 2008; and why it might be worse
Markets are pausing for breath, trying to work out what's coming next
Archive
Proactive news snapshot: Synairgen, Ergomed, Westminster Group, Union Jack Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Synairgen to start COVID-19 trial of lead drug imminently
SNG001 is an inhaled formulation of interferon-beta-1a and is currently being developed to treat people with chronic obstructive pulmonary disease
Coronavirus: Small biotechs buck market trend as search for lung infection relief intensifies
All are in one way or another working on drugs either to help cure lung disease or alleviate the symptoms.
Archive
Proactive snapshot: Synairgen, Bushveld Minerals Limited, KR1
A look at some of the top stories from the Proactive newswire on Monday
Synairgen set for a busy winter
"The company has made good progress on its inhaled broad-spectrum antiviral candidate IFN-beta, designed to treat viral chest infections in patients with COPD."
Synairgen to share encouraging data
The company’s chief scientific officer, Dr Phillip Monk, will deliver the update on Sunday (Sept 29) to the European Respiratory Society International Congress being held in Madrid
Archive
Proactive news snapshot: Synairgen, Active Energy, Arc Minerals...
A glance at some of the day's highlights from the Proactive Investors newswire
Synairgen phase II study making encouraging progress
The company is trialling an inhaled interferon beta treatment in lung disease patients who are also suffering from either a cold or flu